ADmit Therapeutics — Pre-seed · €200K

A €200K first round co-led by Banco Sabadell's BStartup Health and Ship2B's Equity4Good, with GENESIS Biomed and private investors who were not named. The money went into developing its blood-based test for early detection of Alzheimer's disease.

LeadBStartup (Banco Sabadell), Equity4Good (Ship2B) RoundPre-seed Announced18 Mar 2019 CityEsplugues de Llobregat SectorHealthtech & Bio · Biotech / Diagnostics Source P

Something wrong? Suggest a correction →